Compare ACON & AQMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACON | AQMS |
|---|---|---|
| Founded | 2008 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Metal Fabrications |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0M | 5.2M |
| IPO Year | 2022 | 2015 |
| Metric | ACON | AQMS |
|---|---|---|
| Price | $1.59 | $1.38 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | ★ $7.63 | $5.00 |
| AVG Volume (30 Days) | 12.9K | ★ 30.4K |
| Earning Date | 11-24-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 99.82 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $75,730.00 | ★ $2,100,000.00 |
| Revenue This Year | $44.55 | N/A |
| Revenue Next Year | $123.97 | $600.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 65.62 | N/A |
| 52 Week Low | $1.54 | $1.02 |
| 52 Week High | $9.36 | $8.39 |
| Indicator | ACON | AQMS |
|---|---|---|
| Relative Strength Index (RSI) | 33.47 | 37.88 |
| Support Level | N/A | $1.02 |
| Resistance Level | $3.54 | $2.98 |
| Average True Range (ATR) | 0.11 | 0.18 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 9.62 | 55.93 |
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.
Aqua Metals Inc is developing and seeking to commercialize proprietary recycling and refining technologies for the recovery of critical minerals and metals. Its patented and patent-pending AquaRefining process is an electro-hydrometallurgical method designed to recover high-purity materials from battery and other metal-bearing feedstocks using a closed-loop system powered by electricity. Its idea is to reduce CAPEX and OPEX costs, reduce emissions, hazardous waste, and reliance on conventional smelting and chemical-intensive refining processes. It has one operating segment: sustainable metals recycling. It focused on the development and commercialization of AquaRefining technology for the clean and efficient recovery of valuable metals from lead-acid and lithium-ion batteries.